Literature DB >> 17948146

Chronic obstructive pulmonary disease.

N R Anthonisen1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17948146      PMCID: PMC2677791          DOI: 10.1155/2007/986892

Source DB:  PubMed          Journal:  Can Respir J        ISSN: 1198-2241            Impact factor:   2.409


× No keyword cloud information.
  21 in total

1.  Susceptibility genes for rapid decline of lung function in the lung health study.

Authors:  A J Sandford; T Chagani; T D Weir; J E Connett; N R Anthonisen; P D Paré
Journal:  Am J Respir Crit Care Med       Date:  2001-02       Impact factor: 21.405

2.  Pulmonary function in ambulatory asthmatics.

Authors:  B J Sobol; C Emirgil
Journal:  J Chronic Dis       Date:  1976-04

3.  The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial.

Authors:  Nicholas R Anthonisen; Melissa A Skeans; Robert A Wise; Jure Manfreda; Richard E Kanner; John E Connett
Journal:  Ann Intern Med       Date:  2005-02-15       Impact factor: 25.391

4.  The lung's "quiet zone".

Authors:  J Mead
Journal:  N Engl J Med       Date:  1970-06-04       Impact factor: 91.245

5.  Dynamic hyperinflation and exercise intolerance in chronic obstructive pulmonary disease.

Authors:  D E O'Donnell; S M Revill; K A Webb
Journal:  Am J Respir Crit Care Med       Date:  2001-09-01       Impact factor: 21.405

6.  Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study.

Authors:  N R Anthonisen; J E Connett; J P Kiley; M D Altose; W C Bailey; A S Buist; W A Conway; P L Enright; R E Kanner; P O'Hara
Journal:  JAMA       Date:  1994-11-16       Impact factor: 56.272

7.  Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Report of the Medical Research Council Working Party.

Authors: 
Journal:  Lancet       Date:  1981-03-28       Impact factor: 79.321

8.  Smoking and lung function of Lung Health Study participants after 11 years.

Authors:  Nicholas R Anthonisen; John E Connett; Robert P Murray
Journal:  Am J Respir Crit Care Med       Date:  2002-09-01       Impact factor: 21.405

9.  Prognosis in chronic obstructive pulmonary disease.

Authors:  N R Anthonisen; E C Wright; J E Hodgkin
Journal:  Am Rev Respir Dis       Date:  1986-01

10.  Intermittent positive pressure breathing therapy of chronic obstructive pulmonary disease. A clinical trial.

Authors: 
Journal:  Ann Intern Med       Date:  1983-11       Impact factor: 25.391

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.